What is Double Helix?
Double Helix Optics is at the forefront of nanoscale 3D imaging and sensing, utilizing Nobel Prize-winning super-resolution microscopy techniques. Their proprietary SPINDLE modules and 3DTRAX software empower researchers to achieve unprecedented molecular-level imaging precision. The company's innovative solutions cater to a broad spectrum of scientific disciplines, including cell biology, disease discovery, and neuroscience, thereby accelerating scientific research and fostering innovation in the life sciences sector.
How much funding has Double Helix raised?
Double Helix has raised a total of $1.1M across 2 funding rounds:
Other Financing Round
$1M
Debt
$106K
Other Financing Round (2018): $1M, investors not publicly disclosed
Debt (2021): $106K led by PPP
Key Investors in Double Helix
PPP
Public-Private Partnership
What's next for Double Helix?
The substantial enterprise-level funding, coupled with the recent strategic investment, positions Double Helix for significant growth. This capital infusion is expected to fuel advancements in their super-resolution microscopy technology, potentially expanding their market reach into new research areas and commercial applications. The company's focus on enabling molecular-level insights suggests a trajectory towards becoming a key player in advanced scientific instrumentation, driving further breakthroughs in biological and medical research.
See full Double Helix company page
